国药集团新冠灭活疫苗在巴林获批上市

收藏
关键词: 疫苗国药上市获批
资讯来源:CMEF中国国际医疗器械博览会
所属行业:化学药制剂
发布时间: 2020-12-14

巴林国家卫生监管局官方消息,在G42 Healthcare(中国国药集团在中东和北非的独家经销商)提交了上市所需相关文件后,巴林国家卫生监管局已正式批准国药集团中国生物研发的新冠灭活疫苗在巴林王国注册上市。以下是官方原文


National Health Regulatory Authority approves Sinopharm COVID-19 vaccine


Manama, Dec. 13 (BNA): The National Health Regulatory Authority (NHRA) today announced it has officially approved the registration of Sinopharm’s COVID-19 vaccine after the submission of all related documentation by G42 Healthcare, the company’s exclusive distributor in the Middle East and North Africa.


The NHRA’s decision to approve and use the vaccine is based on the clinical trials data conducted across several countries, which was thoroughly reviewed and evaluated by the Authority. Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of COVID-19, following testing on 42,299 volunteers


The NHRA further verified the quality of the vaccine by reviewing the scientific data behind the manufacturing process and the stability of the product, in addition to ensuring the manufacturer's commitment to applying the principles of Good Manufacturing Practice (GMP), in accordance to international standards in the pharmaceutical industry and requirements issued by the NHRA.


Additionally, the NHRA also consulted with the Clinical Research Committee at NHRA, comprised of medical specialists, researchers, academics and doctors, also responsible for approving clinical trials, as well as the approval of the immunization committee.


It is worth noting that the Kingdom of Bahrain has participated in Phase III clinical trials of the vaccine as part of the 4 Humanity campaign, in which more than 7,700 volunteers signed up. The Authority had previously authorized the emergency use of Sinopharm’s vaccine based on preliminary results, which was provided to frontline professionals in contact with COVID-19 patients.


·END·

内容来源|巴林国家卫生监管局、国药集团


展位预定

第84届CMEF将定于2021年5月13-16日在老地方国家会展中心(上海)隆重举行,展位预定通道现已开启,欢迎点击底部“阅读原文”进行展位预定。也欢迎进入iCMEF全球大健康产业空间预定展位,还有更多惊喜等着您!



展会回顾


10月22日,为期四天的CMEF2020完美收官。错过的或者觉得意犹未尽的朋友们,欢迎扫描回顾二维码进入展会回顾页,CMEF2020盛况一览无余。同时,CMEF官方视频号已正式上线,更多精彩展会视频内容等你来看,赶快点击了解详情!


展会回顾页二维码

最后记得关注

还有没关注的么!记得扫描下方二维码关注官微!

此外,因为公众号平台更改了推送规则,如果不想错过CMEF的一手动态,记得读完点一下“在看”&"点赞"&"收藏"三连,这样每次新文章推送才会第一时间出现在你的订阅列表里哦!